Zai Lab Announces Participation in March Investor Conference
Zai Lab Limited (ZLAB) senior management team to participate in Leerink Partners Global Biopharma Conference 2024 in Miami Beach on March 11, 2024, with a live webcast available on the company's Investor Relations page.
03/06/2024 - 07:30 AM
SHANGHAI & CAMBRIDGE, Mass. --(BUSINESS WIRE)--
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that members of the Company’s senior management team will participate in the following investor conference in March 2024:
Leerink Partners Global Biopharma Conference 2024
Presentation: Monday, March 11, 2024, 4:00 p.m. ET
Miami Beach
A live webcast of the presentation will be available on the Investor Relations page of Zai Lab’s website at ir.zailaboratory.com/webcasts-presentations and an archived replay will be available for up to 90 days following the completion of the event.
About Zai Lab
Zai Lab (NASDAQ: ZLAB; HKEX: 9688) is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the United States . We are focused on discovering, developing, and commercializing innovative products that address medical conditions with significant unmet needs in the areas of oncology, autoimmune disorders, infectious diseases, and neuroscience. Our goal is to leverage our competencies and resources to positively impact human health in China and worldwide.
For additional information about Zai Lab, please visit www.zailaboratory.com or follow us at www.twitter.com/ZaiLab_Global .
View source version on businesswire.com: https://www.businesswire.com/news/home/20240306695050/en/
For more information:
I nvestor Relations:
christine.chiou1@zailaboratory.com / lina.zhang@zailaboratory.com
Media:
shaun.maccoun@zailaboratory.com / xiaoyu.chen@zailaboratory.com
Source: Zai Lab Limited
When will Zai Lab Limited's senior management team participate in Leerink Partners Global Biopharma Conference 2024?
Zai Lab Limited's senior management team will participate in Leerink Partners Global Biopharma Conference 2024 on Monday, March 11, 2024, at 4:00 p.m. ET.
Where will the conference take place?
The conference will take place at Fontainebleau, Miami Beach.
Will there be a live webcast of the presentation?
Yes, a live webcast of the presentation will be available on the Investor Relations page of Zai Lab's website at ir.zailaboratory.com/webcasts-presentations.
How long will the archived replay be available?
The archived replay will be available for up to 90 days following the completion of the event.
ZLAB Rankings
#1648 Ranked by Stock Gains
ZLAB Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Health Technology, Biotechnology, Manufacturing, Pharmaceutical Preparation Manufacturing
Country
China (Mainland)
City
Shanghai
About ZLAB
zai lab is a biopharmaceutical company dedicated to discovering, developing and commercializing innovative medicines. our vision is to address the largest unmet medical needs and transform patients’ lives around the world. we take a unique approach to combine both in-licensed products and internal r&d; to achieve a rich pipeline. we believe our drug candidates can be truly disease modifying and bring significant benefits to patients. the company was founded in 2013 by a group of industry veterans. the founders are known as pioneers in china’s fast advancing biotech industry with a proven track record for successful chinese cfda and us fda filings and approvals. our senior management team introduced fast regulatory approval pathways in china and developed a variety of partnership models with multinational pharmaceutical companies. we endeavor to conduct world class clinical development in china and beyond. zai lab has strong backing from a leading group of healthcare investors. our inve
